These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28427232)

  • 21. Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis.
    Hasselblatt M; Thomas C; Hovestadt V; Schrimpf D; Johann P; Bens S; Oyen F; Peetz-Dienhart S; Crede Y; Wefers A; Vogel H; Riemenschneider MJ; Antonelli M; Giangaspero F; Bernardo MC; Giannini C; Ud Din N; Perry A; Keyvani K; van Landeghem F; Sumerauer D; Hauser P; Capper D; Korshunov A; Jones DT; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Kool M
    Acta Neuropathol; 2016 Jul; 132(1):149-51. PubMed ID: 27067307
    [No Abstract]   [Full Text] [Related]  

  • 22. Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development.
    Vitte J; Gao F; Coppola G; Judkins AR; Giovannini M
    Nat Commun; 2017 Aug; 8(1):300. PubMed ID: 28824165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathology and diagnosis of SMARCB1-deficient tumors.
    Margol AS; Judkins AR
    Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
    Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
    Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Pluripotent Stem Cell-Derived Tumor Model Uncovers the Embryonic Stem Cell Signature as a Key Driver in Atypical Teratoid/Rhabdoid Tumor.
    Terada Y; Jo N; Arakawa Y; Sakakura M; Yamada Y; Ukai T; Kabata M; Mitsunaga K; Mineharu Y; Ohta S; Nakagawa M; Miyamoto S; Yamamoto T; Yamada Y
    Cell Rep; 2019 Mar; 26(10):2608-2621.e6. PubMed ID: 30840885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhabdoid tumor of the liver: Report of 6 pediatric cases treated at a single institute.
    Cornet M; De Lambert G; Pariente D; Planchon JM; Guettier C; Martelli H; Guérin F; Branchereau S
    J Pediatr Surg; 2018 Mar; 53(3):567-571. PubMed ID: 28966010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 Years.
    Schweizer Y; Meszaros Z; Jones DTW; Koelsche C; Boudalil M; Fiesel P; Schrimpf D; Piro RM; Brehmer S; von Deimling A; Kerl U; Seiz-Rosenhagen M; Capper D
    J Neuropathol Exp Neurol; 2017 Aug; 76(8):655-664. PubMed ID: 28789476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics.
    Johann PD; Altendorf L; Efremova EM; Holsten T; Steinbügl M; Nemes K; Eckhardt A; Kresbach C; Bockmayr M; Koch A; Haberler C; Antonelli M; DeSisto J; Schuhmann MU; Hauser P; Siebert R; Bens S; Kool M; Green AL; Hasselblatt M; Frühwald MC; Schüller U
    Acta Neuropathol; 2023 Sep; 146(3):527-541. PubMed ID: 37450044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
    Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
    BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.
    Carugo A; Minelli R; Sapio L; Soeung M; Carbone F; Robinson FS; Tepper J; Chen Z; Lovisa S; Svelto M; Amin S; Srinivasan S; Del Poggetto E; Loponte S; Puca F; Dey P; Malouf GG; Su X; Li L; Lopez-Terrada D; Rakheja D; Lazar AJ; Netto GJ; Rao P; Sgambato A; Maitra A; Tripathi DN; Walker CL; Karam JA; Heffernan TP; Viale A; Roberts CWM; Msaouel P; Tannir NM; Draetta GF; Genovese G
    Cancer Cell; 2019 Feb; 35(2):204-220.e9. PubMed ID: 30753823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep intronic hotspot variant explaining rhabdoid tumor predisposition syndrome in two patients with atypical teratoid and rhabdoid tumor.
    Tauziède-Espariat A; Masliah-Planchon J; Brugières L; Puget S; Dufour C; Schneider P; Laquerrière A; Frebourg T; Bodet D; Lechapt-Zalcman E; Pierron G; Delattre O; Varlet P; Bourdeaut F
    Eur J Hum Genet; 2017 Oct; 25(10):1170-1172. PubMed ID: 28722703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Diagnostic Pitfall: Atypical Teratoid Rhabdoid Tumor Versus Dedifferentiated/Poorly Differentiated Chordoma: Analysis of a Mono-institutional Series.
    Buccoliero AM; Caporalini C; Scagnet M; Baroni G; Moscardi S; Mussa F; Giordano F; Sardi I; Genitori L
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):147-154. PubMed ID: 28777153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors.
    Phi JH; Sun CH; Lee SH; Lee S; Park I; Choi SA; Park SH; Lee JY; Wang KC; Kim SK; Yun H; Park CK
    BMC Cancer; 2019 Aug; 19(1):848. PubMed ID: 31462227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor.
    Fukushima H; Yamasaki K; Sakaida M; Tsujio N; Okuno T; Ishii N; Okada K; Fujisaki H; Matsusaka Y; Sakamoto H; Yoneda A; Hara J; Inoue T
    Pathol Int; 2021 Feb; 71(2):155-160. PubMed ID: 33378586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor.
    Thomas C; Oehl-Huber K; Bens S; Soschinski P; Koch A; Nemes K; Oyen F; Kordes U; Kool M; Frühwald MC; Hasselblatt M; Siebert R
    Genes Chromosomes Cancer; 2021 Aug; 60(8):586-590. PubMed ID: 33896072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SWI/SNF-deficient thoraco-pulmonary neoplasms.
    Sesboue C; Le Loarer F
    Semin Diagn Pathol; 2021 May; 38(3):183-194. PubMed ID: 33451916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal Medullary Carcinomas Harbor a Distinct Methylation Phenotype and Display Aberrant Methylation of Genes Related to Early Nephrogenesis.
    Fincke VE; Krulik ME; Joshi P; Frühwald MC; Chen YB; Johann PD
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ewing Sarcoma and Atypical Teratoid Rhabdoid Tumor: A FISH and Immunohistochemical Comparison.
    Pacheco MC; Dolan M; Bendel A
    Pediatr Dev Pathol; 2017; 20(5):381-386. PubMed ID: 28382842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. INI1/SMARCB1-Deficient Carcinoma (Rhabdoid Tumor) of the Lacrimal Gland.
    Srinivasan A; Tuluc M; Jordan AJ; Curry JM; Bilyk JR
    Ophthalmic Plast Reconstr Surg; 2019; 35(2):e41-e43. PubMed ID: 30856630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
    Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
    J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.